Clinical investigation in Duchenne muscular dystrophy: Penicillamine and vitamin E

Gerald M. Fenichel, Michael H. Brooke, Robert C. Griggs, Jerry R. Mendell, J. Phillip Miller, Richard T. Moxley, Jane H. Park, Michael A. Provine, Julaine Florence, Kenneth K. Kaiser, Wendy M. King, Shree Pandya, Jenny Robison, Linda Signore

Research output: Contribution to journalArticle

33 Scopus citations

Abstract

A double‐blind controlled trial of penicillamine and vitamin E against placebo was conducted in 106 boys with Duchenne muscular dystrophy. Nine dropped out of the study after being randomized. Patients were evaluated using an established protocol that measures muscle strength, joint contractures, functional grade, and pulmonary function. The trial lasted for 18 months. The power of the study to detect a 75% slowing of the disease was 0.95 at a P < 0.05. No therapeutic effect was observed in the patients taking penicillamine and vitamin E as compared with those taking placebo.

Original languageEnglish
Pages (from-to)1164-1168
Number of pages5
JournalMuscle & Nerve
Volume11
Issue number11
DOIs
StatePublished - Nov 1988

Fingerprint Dive into the research topics of 'Clinical investigation in Duchenne muscular dystrophy: Penicillamine and vitamin E'. Together they form a unique fingerprint.

  • Cite this

    Fenichel, G. M., Brooke, M. H., Griggs, R. C., Mendell, J. R., Miller, J. P., Moxley, R. T., Park, J. H., Provine, M. A., Florence, J., Kaiser, K. K., King, W. M., Pandya, S., Robison, J., & Signore, L. (1988). Clinical investigation in Duchenne muscular dystrophy: Penicillamine and vitamin E. Muscle & Nerve, 11(11), 1164-1168. https://doi.org/10.1002/mus.880111110